Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings symbols : TAK save search
Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D Priorities
Published: 2024-02-13 (Crawled : 19:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: 0.14%
H: 0.35%
C: 0.07%
XNCR | $18.6 2.14% 220K
|
Health Technology
|
| O: -3.56%
H: 2.91%
C: -3.34%
MOR | News | $18.01 0.28% 130K
|
Health Technology
|
| O: -0.4%
H: 0.23%
C: -0.46%
MGNX | $16.485 6.98% 250K
|
Health Technology
|
| O: -5.25%
H: 2.94%
C: 2.18%
INCY | $52.02 0.19% 1.2M
|
Health Technology
|
| O: 3.8%
H: 1.1%
C: -1.17%
financial
ImmunoGen Reports Recent Progress and Third Quarter 2023 Financial Results
Published: 2023-11-02 (Crawled : 13:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
LLY | News | $741.37 1.37% 800K
|
Health Technology
|
| O: 4.42%
H: 0.0%
C: 0.0%
IMGN | News | $31.23 0.03% 49M
|
Health Technology
|
| O: 5.09%
H: 5.48%
C: -1.27%
financial results
Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2023-10-31 (Crawled : 00:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: 1.05%
H: 0.74%
C: 0.74%
XNCR | $18.6 2.14% 220K
|
Health Technology
|
| O: -0.41%
H: 2.1%
C: 1.11%
MOR | News | $18.01 0.28% 130K
|
Health Technology
|
| O: 4.23%
H: 0.12%
C: -1.97%
MGNX | $16.485 6.98% 250K
|
Health Technology
|
| O: 0.0%
H: 2.13%
C: 1.16%
INCY | $52.02 0.19% 1.2M
|
Health Technology
|
| O: -0.39%
H: 4.09%
C: 3.8%
financial results
Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2023-08-01 (Crawled : 15:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: -2.23%
H: 2.28%
C: 1.34%
XNCR | $18.6 2.14% 220K
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
REPL | $6.685 4.13% 160K
|
Health Technology
|
| O: 2.63%
H: 1.14%
C: -2.65%
MOR | News | $18.01 0.28% 130K
|
Health Technology
|
| O: -0.14%
H: 4.77%
C: 4.77%
MGNX | $16.485 6.98% 250K
|
Health Technology
|
| O: 0.0%
H: 4.19%
C: 2.31%
INCY | $52.02 0.19% 1.2M
|
Health Technology
|
| O: 2.75%
H: 0.44%
C: -2.72%
financial results
Neurocrine Biosciences Reports Second Quarter 2023 Financial Results and Raises 2023 INGREZZA Sales Guidance
Published: 2023-08-01 (Crawled : 15:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: -2.23%
H: 2.28%
C: 1.34%
NBIX | News M | $139.71 4.53% 760K
|
Health Technology
|
| O: 0.6%
H: 1.95%
C: 0.92%
sales ingrezza financial results
Takeda Delivers Strong Revenue and Profit Growth in FY2022; Updated Capital Allocation Policy Reflects Deleveraging Progress and Confidence in Growth Outlook
Published: 2023-05-11 (Crawled : 09:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: -1.83%
H: 0.12%
C: -3.06%
fy2022 growth
Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs
Published: 2023-02-07 (Crawled : 13:00) - biospace.com/
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 2.27%
H: 0.0%
C: 0.0%
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: -0.13%
H: 1.01%
C: 0.89%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: 0.29%
H: 0.86%
C: 0.72%
XNCR | $18.6 2.14% 220K
|
Health Technology
|
| O: -0.19%
H: 1.15%
C: -2.27%
MOR | News | $18.01 0.28% 130K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -0.59%
INCY | $52.02 0.19% 1.2M
|
Health Technology
|
| O: -1.02%
H: 0.29%
C: -3.04%
financial
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: 0.68%
H: 1.05%
C: -0.23%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: 0.47%
H: 0.09%
C: -0.55%
XNCR | $18.6 2.14% 220K
|
Health Technology
|
| O: 1.07%
H: 2.51%
C: -0.11%
MOR | News | $18.01 0.28% 130K
|
Health Technology
|
| O: 3.1%
H: 1.8%
C: -0.6%
INCY | $52.02 0.19% 1.2M
|
Health Technology
|
| O: 1.59%
H: 7.26%
C: 1.89%
financial results
Neurocrine Biosciences Reports Third Quarter 2022 Financial Results and Raises 2022 INGREZZA Sales Guidance
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: 0.68%
H: 1.05%
C: -0.23%
NBIX | News M | $139.71 4.53% 760K
|
Health Technology
|
| O: -0.1%
H: 7.37%
C: 3.79%
sales ingrezza financial results
Takeda Delivers Strong FY2022 H1 Results and Raises Full-Year Forecast
Published: 2022-10-27 (Crawled : 08:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: 1.0%
H: 2.44%
C: -0.46%
fy2022 results
LogicBio Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-15 (Crawled : 12:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: -0.63%
H: 0.85%
C: 0.56%
LOGC | $2.07 -0.48%
|
Health Technology
|
| O: -4.76%
H: 3.33%
C: -14.17%
therapeutics update results
Incyte Reports 2022 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-08-02 (Crawled : 12:00) - biospace.com/
NVSEF | News | $95.11 490
|
Health Technology
|
| O: -2.62%
H: 0.0%
C: 0.0%
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: -1.33%
H: 0.78%
C: -1.06%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: -0.02%
H: 0.39%
C: -0.64%
XNCR | $18.6 2.14% 220K
|
Health Technology
|
| O: -0.32%
H: 5.09%
C: 3.9%
MOR | News | $18.01 0.28% 130K
|
Health Technology
|
| O: -3.37%
H: 3.3%
C: 0.92%
INCY | $52.02 0.19% 1.2M
|
Health Technology
|
| O: -4.39%
H: 0.2%
C: -1.92%
results
Takeda Delivers Strong FY2021 Results; Continued Growth Momentum Expected in FY2022
Published: 2022-05-11 (Crawled : 09:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: -1.25%
H: 0.35%
C: -2.38%
fy2021 fy2022 expected growth
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress
Published: 2022-02-28 (Crawled : 22:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: 0.54%
H: 1.66%
C: 1.13%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
ARCT 4 | $28.69 6.02% 140K
|
Health Technology
|
| O: -0.93%
H: 3.16%
C: 2.35%
ces therapeutics
Arcturus Therapeutics to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update on February 28, 2022
Published: 2022-02-16 (Crawled : 14:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: -0.07%
H: 0.59%
C: 0.53%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: -0.49%
H: 0.81%
C: 0.43%
ARCT 4 | $28.69 6.02% 140K
|
Health Technology
|
| O: -2.58%
H: 1.98%
C: 1.07%
financial results therapeutics report results
Takeda Delivers Strong Third Quarter FY2021 Results and Raises Full-Year Forecast Reflecting Strong Momentum
Published: 2022-02-03 (Crawled : 08:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: 0.55%
H: 1.5%
C: -1.3%
fy2021 liver results
Arrowhead Pharmaceuticals Reports Fiscal 2022 First Quarter Results
Published: 2022-02-02 (Crawled : 00:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: -0.99%
H: 0.0%
C: 0.0%
ARWR | $24.25 1.38% 380K
|
Health Technology
|
| O: 0.2%
H: 0.0%
C: 0.0%
als report results
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2021 Net Product Sales Results and Future Program Milestones
Published: 2022-01-06 (Crawled : 00:00) - biospace.com/
PPRUF | News | $364.27 850
|
Consumer Non-Durables
|
| O: 2.64%
H: 0.0%
C: -0.39%
PPRUY | News | $36.96 220K
|
Manufacturing
|
| O: -0.99%
H: 0.0%
C: -1.16%
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: 1.0%
H: 0.0%
C: 0.0%
NBIX | News M | $139.71 4.53% 760K
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
sales bioscience milestone
Novavax Reports Third Quarter 2021 Financial Results and Operational Highlights
Published: 2021-11-04 (Crawled : 23:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: 0.35%
H: 0.91%
C: 0.77%
NVAX | $4.22 3.69% 2M
|
Health Technology
|
| O: -5.97%
H: 2.42%
C: -2.26%
financial results results
Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-11-02 (Crawled : 12:00) - biospace.com/
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: 0.49%
H: 0.56%
C: -0.07%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: 0.3%
H: 0.15%
C: -0.4%
XNCR | $18.6 2.14% 220K
|
Health Technology
|
| O: 2.7%
H: 1.01%
C: 0.85%
MOR | News | $18.01 0.28% 130K
|
Health Technology
|
| O: 3.75%
H: 1.22%
C: 1.22%
INCY | $52.02 0.19% 1.2M
|
Health Technology
|
| O: -1.93%
H: 0.19%
C: -3.14%
financial results results
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.7945 32.42% 3.1M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
BTCM | $3.45 27.78% 640K
|
Arts, Entertainment, and Recrea...
PALI | $6.29 27.59% 22M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.